These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24389668)

  • 1. Blocking the interaction between HIV-1 integrase and human LEDGF/p75: mutational studies, virtual screening and molecular dynamics simulations.
    Reddy KK; Singh P; Singh SK
    Mol Biosyst; 2014 Mar; 10(3):526-36. PubMed ID: 24389668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the interactions between HIV-1 integrase and human LEDGF/p75 by molecular dynamics simulation and free energy calculation.
    Zhao Y; Li W; Zeng J; Liu G; Tang Y
    Proteins; 2008 Aug; 72(2):635-45. PubMed ID: 18247352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
    De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
    ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational studies of the interaction between the HIV-1 integrase tetramer and the cofactor LEDGF/p75: insights from molecular dynamics simulations and the informational spectrum method.
    Tintori C; Veljkovic N; Veljkovic V; Botta M
    Proteins; 2010 Dec; 78(16):3396-408. PubMed ID: 20878714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based virtual screening toward the discovery of novel inhibitors for impeding the protein-protein interaction between HIV-1 integrase and human lens epithelium-derived growth factor (LEDGF/p75).
    Panwar U; Singh SK
    J Biomol Struct Dyn; 2018 Sep; 36(12):3199-3217. PubMed ID: 28948865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
    Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
    J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
    Christ F; Debyser Z
    Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the fundamental interactions between LEDGF binding site inhibitors and integrase combining docking and molecular dynamics simulations.
    De Luca L; Morreale F; Chimirri A
    J Chem Inf Model; 2012 Dec; 52(12):3245-54. PubMed ID: 23194297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small peptides inhibiting the integrase-LEDGF/p75 interaction through targeting the cellular co-factor.
    Cavalluzzo C; Christ F; Voet A; Sharma A; Singh BK; Zhang KY; Lescrinier E; De Maeyer M; Debyser Z; Van der Eycken E
    J Pept Sci; 2013 Oct; 19(10):651-8. PubMed ID: 24014475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecules targeting the interaction between HIV-1 integrase and LEDGF/p75 cofactor.
    De Luca L; Ferro S; Gitto R; Barreca ML; Agnello S; Christ F; Debyser Z; Chimirri A
    Bioorg Med Chem; 2010 Nov; 18(21):7515-21. PubMed ID: 20850978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75.
    Bartholomeeusen K; De Rijck J; Busschots K; Desender L; Gijsbers R; Emiliani S; Benarous R; Debyser Z; Christ F
    J Mol Biol; 2007 Sep; 372(2):407-21. PubMed ID: 17669426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.
    Xue W; Liu H; Yao X
    PLoS One; 2014; 9(3):e90799. PubMed ID: 24599328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75.
    De Luca L; Ferro S; Morreale F; De Grazia S; Chimirri A
    ChemMedChem; 2011 Jul; 6(7):1184-91. PubMed ID: 21506277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New scaffolds of natural origin as Integrase-LEDGF/p75 interaction inhibitors: virtual screening and activity assays.
    De Luca L; Morreale F; Christ F; Debyser Z; Ferro S; Gitto R
    Eur J Med Chem; 2013 Oct; 68():405-11. PubMed ID: 23994868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor.
    Gu WG; Ip DT; Liu SJ; Chan JH; Wang Y; Zhang X; Zheng YT; Wan DC
    Chem Biol Interact; 2014 Apr; 213():21-7. PubMed ID: 24480521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual-screening targeting Human Immunodeficiency Virus type 1 integrase-lens epithelium-derived growth factor/p75 interaction for drug development.
    Gu WG; Liu BN; Yuan JF
    J Drug Target; 2015 Feb; 23(2):134-9. PubMed ID: 25230778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [LEDGF/p75: a novel target for anti-HIV therapy and advances in the study of its related inhibitors].
    Chen WM; Liu XY
    Yao Xue Xue Bao; 2009 Sep; 44(9):953-60. PubMed ID: 20055168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
    Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
    PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational and synthetic approaches for developing Lavendustin B derivatives as allosteric inhibitors of HIV-1 integrase.
    Agharbaoui FE; Hoyte AC; Ferro S; Gitto R; Buemi MR; Fuchs JR; Kvaratskhelia M; De Luca L
    Eur J Med Chem; 2016 Nov; 123():673-683. PubMed ID: 27517812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase.
    Zheng Y; Ao Z; Jayappa KD; Yao X
    Virol J; 2010 Mar; 7():68. PubMed ID: 20331877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.